UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The influence of deprivation in the outcomes of psoriatic arthritis within the UK-utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data

Rheumatology advances in practice, 2024, Vol.8 (2), p.rkae051

2024

Volltextzugriff (PDF)

Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response

Rheumatology advances in practice, 2024, Vol.8 (1), p.rkae014-rkae014

2024

Volltextzugriff (PDF)

Comment on: Residual disease activity in psoriatic arthritis: discordance between the rheumatologist's opinion and minimal disease activity measurement

Rheumatology (Oxford, England), 2018-02, Vol.57 (2), p.401-402

Tillett, William

2018

Volltextzugriff (PDF)

Diagnosis, classification, and assessment in psoriatic arthritis

Best practice & research. Clinical rheumatology, 2021-06, Vol.35 (2), p.101669-101669, Article 101669

2021

Volltextzugriff (PDF)

Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial

Arthritis research & therapy, 2023-09, Vol.25 (1), p.1-169, Article 169

2023

Volltextzugriff (PDF)

Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis

British journal of dermatology (1951), 2020-03, Vol.182 (3), p.714-720

2020

Volltextzugriff (PDF)

Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis

Arthritis research & therapy, 2024-02, Vol.26 (1), p.50-15, Article 50

2024

Volltextzugriff (PDF)

POS0964 DYNAMIC PREDICTION OF PSORIATIC ARTHRITIS IN A COHORT OF PSORIASIS PATIENTS USING UK PRIMARY CARE ELECTRONIC HEALTH RECORDS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.699-700

2024

Volltextzugriff (PDF)

AB1667-PARE TREATMENT SATISFACTION FOR MEDICATIONS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.2209-2209

2024

Volltextzugriff (PDF)

Work disability in psoriatic arthritis: a systematic review

Rheumatology (Oxford, England), 2012-02, Vol.51 (2), p.275-283

2012

Volltextzugriff (PDF)

POS1084 COMPARISON OF NUMERICAL RATING SCALE (NRS) AND VISUAL ANALOGUE SCALE (VAS) IN THE PATIENT REPORTED OUTCOME MEASURES OF 3VAS AND 4VAS IN PSORIATIC ARTHRITIS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.821-821

2021

Volltextzugriff (PDF)

AB1725-PARE SEQUENCE PATIENT SURVEY: PERCEPTION OF THE USE OF ADVANCED THERAPIES FOR PSORIATIC ARTHRITIS IN THE UNITED KINGDOM

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.2099-2100

2023

Volltextzugriff (PDF)

AB1569 THE USE OF MACHINE LEARNING IN DIAGNOSING AND DETECTING DAMAGE IN THE HANDS AND FEET OF PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: A SCOPING REVIEW

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.2017-2018

2023

Volltextzugriff (PDF)

AB1575 A RELIABLE METHOD FOR ANNOTATING HAND AND WRIST X-RAYS FOR SUPERVISED MACHINE LEARNING ALGORITHMS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.2020-2021

2023

Volltextzugriff (PDF)

Using Bayesian networks to identify musculoskeletal symptoms influencing the risk of developing psoriatic arthritis in people with psoriasis

Rheumatology (Oxford, England), 2022-02, Vol.61 (2), p.581-590

2022

Volltextzugriff (PDF)

The evolving demographics of participants in psoriatic arthritis phase III randomised controlled trials of b/tsDMARDs: A systematic review

Seminars in arthritis and rheumatism, 2023-06, Vol.60, p.152175-152175, Article 152175

2023

Volltextzugriff (PDF)

OP0224 CONTINUOUS COMPOSITE MEASURES FOR ROUTINE CARE IN PSORIATIC ARTHRITIS: THRESHOLDS OF MEANING AND CLINICALLY IMPORTANT DIFFERENCE ESTIMATES FOR THE 3 AND 4 VAS SCALES FROM A UK MULTICENTRE STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.135-135

2021

Volltextzugriff (PDF)

AB0803 EXPERIENCES OF SCREENING AND DIAGNOSIS FROM THE PERSPECTIVE OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS (PSA)

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1426-1426

2021

Volltextzugriff (PDF)

Effectiveness of sequential lines of biologic and targeted small-molecule drugs in psoriatic arthritis: a systematic review

Rheumatology (Oxford, England), 2024-07, Vol.63 (7), p.1790-1802

2024

Volltextzugriff (PDF)

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2

Annals of the rheumatic diseases, 2021-03, Vol.80 (3), p.312-320

2021

Volltextzugriff (PDF)

Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis

Annals of the rheumatic diseases, 2013-08, Vol.72 (8), p.1358-1361

2013

Volltextzugriff (PDF)

Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study

Clinical and experimental rheumatology, 2023-11

2023

Volltextzugriff (PDF)

Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study

Rheumatic & musculoskeletal diseases open, 2023-01, Vol.9 (1), p.e002533

2023

Volltextzugriff (PDF)

Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group

Journal of rheumatology, 2023-11, Vol.50 (Suppl 2), p.53-57

2023

Volltextzugriff (PDF)

The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study

Journal of rheumatology, 2012-01, Vol.39 (1), p.154

2012

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Aktive Filter

SpracheArabisch

ThemaPsoriatic Arthritis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(134)
Buchkapitel
(1)

Sprache

Englisch
(135)

Erscheinungsjahr

n.n

Thema

Rheumatology
(98)
Life Sciences & Biomedicine
(86)
Science & Technology
(86)
Psoriasis
(68)
Patients
(53)
Humans
(52)
Arthritis
(36)
Quality Of Life
(29)
Clinical Trials
(27)
Arthritis, Psoriatic - Drug Therapy
(25)
Female
(24)
Arthritis, Psoriatic - Diagnosis
(23)
Male
(22)
Severity Of Illness Index
(22)
Medicine
(18)
Middle Aged
(18)
Adult
(17)
Medicine & Public Health
(16)
Antirheumatic Agents - Therapeutic Use
(15)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

The influence of deprivation in the outcomes of psoriatic arthritis within the UK-utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data

Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response

Comment on: Residual disease activity in psoriatic arthritis: discordance between the rheumatologist's opinion and minimal disease activity measurement

Diagnosis, classification, and assessment in psoriatic arthritis

Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial

Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis

Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis

POS0964 DYNAMIC PREDICTION OF PSORIATIC ARTHRITIS IN A COHORT OF PSORIASIS PATIENTS USING UK PRIMARY CARE ELECTRONIC HEALTH RECORDS

AB1667-PARE TREATMENT SATISFACTION FOR MEDICATIONS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS

Work disability in psoriatic arthritis: a systematic review

POS1084 COMPARISON OF NUMERICAL RATING SCALE (NRS) AND VISUAL ANALOGUE SCALE (VAS) IN THE PATIENT REPORTED OUTCOME MEASURES OF 3VAS AND 4VAS IN PSORIATIC ARTHRITIS

AB1725-PARE SEQUENCE PATIENT SURVEY: PERCEPTION OF THE USE OF ADVANCED THERAPIES FOR PSORIATIC ARTHRITIS IN THE UNITED KINGDOM

AB1569 THE USE OF MACHINE LEARNING IN DIAGNOSING AND DETECTING DAMAGE IN THE HANDS AND FEET OF PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: A SCOPING REVIEW

AB1575 A RELIABLE METHOD FOR ANNOTATING HAND AND WRIST X-RAYS FOR SUPERVISED MACHINE LEARNING ALGORITHMS

Using Bayesian networks to identify musculoskeletal symptoms influencing the risk of developing psoriatic arthritis in people with psoriasis

The evolving demographics of participants in psoriatic arthritis phase III randomised controlled trials of b/tsDMARDs: A systematic review

OP0224 CONTINUOUS COMPOSITE MEASURES FOR ROUTINE CARE IN PSORIATIC ARTHRITIS: THRESHOLDS OF MEANING AND CLINICALLY IMPORTANT DIFFERENCE ESTIMATES FOR THE 3 AND 4 VAS SCALES FROM A UK MULTICENTRE STUDY

AB0803 EXPERIENCES OF SCREENING AND DIAGNOSIS FROM THE PERSPECTIVE OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS (PSA)

Effectiveness of sequential lines of biologic and targeted small-molecule drugs in psoriatic arthritis: a systematic review

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2

Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis

Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study

Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study

Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group

The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study

Aktive Filter

Suchergebnisse filtern